🆕Weekly haemophilia B treatment approved by NICE NICE recommends marstacimab as the first once-weekly subcutaneous (under the skin) injection for people aged 12+ with severe haemophilia B. This replaces factor 9 replacement therapy, often requiring infusions every few days⤵️ https://www.nice.org.uk/news/articles/new-weekly-treatment-option-approved-for-people-with-haemophilia-b?utm_medium=organic&utm_source=whatsapp&utm_campaign=haem_b&utm_content=graphic